Delcath Systems, Inc. (Nasdaq: DCTH) announced that the FDA granted Delcath's request for orphan drug designation for doxorubicin for the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE